|
ZE19 |
Gabe von Irinotecan, parenteral
|
2018 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2017 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2016 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2015 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2014 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2013 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2012 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2011 |
|
ZE19 |
Gabe von Irinotecan, parenteral
|
2010 |
|
ZE27 |
Gabe von Trastuzumab, parenteral
|
2014 |
|
ZE27 |
Gabe von Trastuzumab, parenteral
|
2013 |
|
ZE27 |
Gabe von Trastuzumab, parenteral
|
2012 |
|
ZE27 |
Gabe von Trastuzumab, parenteral
|
2011 |
|
ZE27 |
Gabe von Trastuzumab, parenteral
|
2010 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2025 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2024 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2023 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2022 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2021 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2020 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2019 |
|
ZE30 |
Gabe von Prothrombinkomplex, parenteral
|
2018 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2017 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2016 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2015 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2014 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2013 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2012 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2011 |
|
ZE30 |
Gabe von Prothrombin-komplex, parenteral
|
2010 |
|
ZE36 |
Plasmapherese
|
2025 |
|
ZE36 |
Plasmapherese
|
2024 |
|
ZE36 |
Plasmapherese
|
2023 |
|
ZE36 |
Plasmapherese
|
2022 |
|
ZE36 |
Plasmapherese
|
2021 |
|
ZE36 |
Plasmapherese
|
2020 |
|
ZE36 |
Plasmapherese
|
2019 |
|
ZE36 |
Plasmapherese
|
2018 |
|
ZE36 |
Plasmapherese, therapeutisch
|
2017 |
|
ZE36 |
Plasmapherese
|
2016 |
|
ZE36 |
Plasmapherese
|
2015 |
|
ZE36 |
Plasmapherese
|
2014 |
|
ZE36 |
Plasmapherese
|
2013 |
|
ZE36 |
Plasmapherese
|
2012 |
|
ZE36 |
Plasmapherese
|
2011 |
|
ZE36 |
Plasmapherese
|
2010 |
|
ZE37 |
Extrakorporale Photopherese
|
2025 |
|
ZE37 |
Extrakorporale Photopherese
|
2024 |
|
ZE37 |
Extrakorporale Photopherese
|
2023 |
|
ZE37 |
Extrakorporale Photopherese
|
2022 |
|
ZE37 |
Extrakorporale Photopherese
|
2021 |
|
ZE37 |
Extrakorporale Photopherese
|
2020 |
|
ZE37 |
Extrakorporale Photopherese
|
2019 |
|
ZE37 |
Extrakorporale Photopherese
|
2018 |
|
ZE37 |
Extrakorporale Photopherese
|
2017 |
|
ZE37 |
Extrakorporale Photopherese
|
2016 |
|
ZE37 |
Extrakorporale Photopherese
|
2015 |
|
ZE37 |
Extrakorporale Photopherese
|
2014 |
|
ZE37 |
Extrakorporale Photopherese
|
2013 |
|
ZE37 |
Extrakorporale Photopherese
|
2012 |
|
ZE37 |
Extrakorporale Photopherese
|
2011 |
|
ZE37 |
Extrakorporale Photopherese
|
2010 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2019 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2018 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2017 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2016 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2015 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2014 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2013 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2012 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2011 |
|
ZE40 |
Gabe von Filgrastim, parenteral
|
2010 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2019 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2018 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2017 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2016 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2015 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2014 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2013 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2012 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2011 |
|
ZE42 |
Gabe von Lenograstim, parenteral
|
2010 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2022 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2021 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2020 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2019 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2018 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2017 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2016 |
|
ZE44 |
Gabe von Lenograstim, parenteral
|
2015 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2014 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2012 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2011 |
|
ZE44 |
Gabe von Topotecan, parenteral
|
2010 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2025 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2024 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2023 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2022 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2021 |
|
ZE47 |
Gabe von Antithrombin III, parenteral
|
2020 |